National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

---
identifier: "/us/fr/2016-08994"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2016-08994"
section_name: "National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting"
positive_law: false
currency: "2016-04-19"
last_updated: "2016-04-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2016-08994"
document_type: "notice"
publication_date: "2016-04-19"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "81 FR 22997"
fr_volume: 81
---


#  National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; NIBIB P41 Site Visit (2016/10).

*Date:* May 1-3, 2016.

*Time:* 6:00 p.m. to 12:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* Dallas Marriott Suites Medical/Market Center, 2493 North Stemmons Freeway, Dallas, TX 75207.

*Contact Person:* Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 967, Bethesda, MD 20892, (301) 496-4773, *[email protected].*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

Dated: April 13, 2016.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.